Microvascular Dysplasia in Dogs

Microvascular dysplasia in dogs, also called hepatic microvascular dysplasia or portal vein hypoplasia in some references, is a congenital disorder of the liver’s tiny blood vessels. In affected dogs, the small portal vessels inside the liver are underdeveloped or abnormally arranged, so blood from the intestines does not move through the liver as efficiently as it should. That matters because the liver helps process nutrients, clear toxins, and make important proteins.

This condition is seen most often in small-breed dogs, including Yorkshire Terriers, Maltese, Cairn Terriers, Tibetan Spaniels, Miniature Schnauzers, Pugs, Chihuahuas, and several terrier-type breeds. Some dogs are found during routine screening and have few outward signs. Others develop digestive upset, poor growth, urinary tract issues, or episodes linked to hepatic encephalopathy, which happens when toxins that should be filtered by the liver affect the brain.

Microvascular dysplasia can look a lot like a congenital portosystemic shunt on lab work, especially when bile acids are elevated. The difference is that microvascular dysplasia involves microscopic vessel abnormalities within the liver rather than one large abnormal vessel bypassing the liver. In real practice, some dogs may also have overlapping vascular problems, so your vet may recommend a stepwise workup instead of assuming one diagnosis from a single test.

For pet parents, the big picture is that this is often a manageable chronic condition rather than an immediate crisis. The right plan depends on your dog’s symptoms, lab changes, age, and whether imaging suggests another liver disorder at the same time. Some dogs need only monitoring and diet support, while others need medication and closer follow-up.

Diagnosis usually starts with a history, physical exam, and baseline lab work. Your vet may recommend a complete blood count, chemistry panel, urinalysis, and fasting and post-meal bile acids testing. Dogs with microvascular dysplasia can have elevated bile acids, low blood urea nitrogen, low cholesterol, low albumin, low glucose, or urinary crystals, but no single result proves the diagnosis.

Imaging helps rule out other causes of abnormal liver function. Abdominal ultrasound is commonly used to look at liver size, blood flow patterns, urinary stones, and whether a larger congenital portosystemic shunt can be identified. In some dogs, advanced imaging such as CT angiography is recommended if ultrasound is inconclusive or if your vet wants to better distinguish microvascular disease from a surgically correctable shunt.

Liver sampling may be discussed in selected cases, but it has limits. Merck notes that histologic changes associated with microvascular dysplasia are not always specific enough to cleanly separate this disorder from other causes of reduced portal perfusion. That means biopsy can add useful context, yet it may not answer every question by itself. Diagnosis is often based on the whole picture: breed, age, clinical signs, lab findings, and imaging results.

Because the workup can become layered, many clinics use a spectrum-of-care approach. A dog with mild signs may begin with exam, bloodwork, urinalysis, and bile acids testing. A dog with neurologic episodes, urinary stones, or unclear imaging may need referral diagnostics. Your vet can help prioritize which tests are most likely to change treatment decisions.

Microvascular dysplasia is considered a congenital and likely inherited liver vascular disorder. The main problem is abnormal development of the tiny portal vein branches inside the liver. Because those vessels are too small, missing, or malformed, portal blood does not perfuse the liver normally. This reduces the liver’s ability to process toxins and support normal metabolism.

Breed predisposition is one of the clearest risk factors. Merck and VCA both describe this condition most often in small-breed dogs, especially Yorkshire Terriers, Maltese, Cairn Terriers, Tibetan Spaniels, Miniature Schnauzers, Pugs, Norfolk Terriers, Scottish Terriers, Shetland Sheepdogs, and Chihuahuas. Mixed-breed dogs with ancestry from predisposed lines may also be affected.

Age matters too. Many dogs are identified when they are young, often during puppyhood or early adulthood, because congenital liver disorders tend to show up early. Still, mild cases can be missed for years if the dog has only subtle digestive signs or if abnormal screening tests are not pursued.

Pet parents should also know that microvascular dysplasia can coexist with other liver vascular abnormalities, including portosystemic shunts. That overlap is one reason diagnosis can be tricky. Because inheritance is suspected, affected dogs are generally not considered good breeding candidates, and related dogs may warrant discussion with your vet if they show poor growth or unexplained liver test changes.

There is no guaranteed way to prevent microvascular dysplasia in an individual dog because it is a congenital developmental disorder. Day-to-day prevention is really about reducing complications. That means keeping follow-up appointments, using medications exactly as your vet directs, feeding the recommended diet consistently, and watching for changes in appetite, behavior, vomiting, stool quality, or urination.

For predisposed breeds, early screening can help catch problems before severe signs develop. If a puppy is small for age, has unexplained digestive upset, or comes from a line with known liver vascular disease, your vet may discuss baseline bloodwork and bile acids testing. Early detection does not cure the condition, but it can help your vet build a plan before neurologic or urinary complications appear.

Breeding decisions matter at the population level. Because inheritance is suspected, dogs diagnosed with microvascular dysplasia are generally not ideal breeding candidates. Pet parents working with breeders may want to ask about family history of liver disease, poor growth, elevated bile acids, or portosystemic shunts in related dogs.

At home, avoid making diet or supplement changes without veterinary guidance. Dogs with liver vascular disorders can be sensitive to protein balance, dehydration, and medications that are processed by the liver. Your vet can help you choose the safest preventive routine for your dog’s specific situation.

The outlook for dogs with microvascular dysplasia is often fair to good, especially when signs are mild and the condition is managed early. Many dogs can live comfortably for years with diet changes, periodic lab monitoring, and medication when needed. Some remain only mildly affected and never develop severe neurologic episodes.

Prognosis becomes more guarded when a dog has repeated hepatic encephalopathy, seizures, poor growth, severe urinary stone disease, or another liver vascular abnormality at the same time. In those cases, the challenge is not only the vessel abnormality itself but also the complications it creates. Dogs that respond well to lactulose, diet adjustment, and supportive care often do better than dogs with ongoing uncontrolled signs.

Recovery is usually not a one-time event. This is more often a long-term management condition than a disease that is fully cured. Your vet may recommend repeat bile acids, chemistry panels, urinalysis, and imaging over time to make sure the plan is still working. Medication doses and diet may need adjustment as your dog ages.

If your dog is newly diagnosed, it helps to think in stages. First, stabilize any urgent signs. Next, clarify how severe the liver dysfunction is and whether another condition is present. Then build a sustainable home plan. That approach often gives pet parents the best chance of balancing symptom control, quality of life, and cost range over time.